Osaic Holdings
PYXS icon

Osaic Holdings’s Pyxis Oncology PYXS Stock Holding History

Osaic Holdings’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53.3K Buy
17,721
+4,000
+29% +$7.65K ﹤0.01% 5436
2026
Q1 		$20K Sell
13,721
-3,503
-20% -$5.28K ﹤0.01% 5858
2025
Q4 		$19.8K Buy
17,224
+2,003
+13% +$7.07K ﹤0.01% 5893
2025
Q3 		$19.5K Sell
15,221
-2,500
-14% -$3.6K ﹤0.01% 5943
2025
Q2 		$19.5K Sell
17,721
-4,658
-21% -$5.25K ﹤0.01% 5727
2025
Q1 		$21.9K Hold
22,379
– – ﹤0.01% 5297
2024
Q4 		$34.9K Buy
22,379
+16,558
+284% +$47.8K ﹤0.01% 4955
2024
Q3 		$21.4K Buy
5,821
+1,450
+33% +$5.07K ﹤0.01% 5351
2024
Q2 		$14.5K Buy
4,371
+1,250
+40% +$5.25K ﹤0.01% 5550
2024
Q1 		$13.3K Buy
3,121
+485
+18% +$2.04K ﹤0.01% 5591
2023
Q4 		$4.74K Sell
2,636
-5,150
-66% -$8.82K ﹤0.01% 6202
2023
Q3 		$15.5K Hold
7,786
– – ﹤0.01% 5687
2023
Q2 		$19.9K Sell
7,786
-214
-3% -$679 ﹤0.01% 5570
2023
Q1 		$32.1K Buy
+8,000
New +$16K ﹤0.01% 5276

Other funds holding PYXS

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings's PYXS Position: Q2 2026 in Review

Osaic Holdings increased its Pyxis Oncology (PYXS) stake by 29% in Q2 2026, buying an estimated $7.65K and bringing the position to 17,721 shares worth $53.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5436.

Osaic Holdings first reported a position in PYXS in Q1 2023 and has held it in 14 quarters since. 76 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

  • Osaic Holdings held 17,721 shares of Pyxis Oncology worth $53.3K as of Q2 2026.
  • Osaic Holdings bought 4,000 Pyxis Oncology shares in Q2 2026, an estimated $7.65K.
  • Pyxis Oncology made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5436 holding.
  • Osaic Holdings first reported a position in Pyxis Oncology in Q1 2023 and has held it in 14 quarters since.
  • 76 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.